![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study |
Akihiro Koga, Toshiyuki Matsui, Noritaka Takatsu, Yasumichi Takada, Masahiro Kishi, Yutaka Yano, Takahiro Beppu, Yoichiro Ono, Kazeo Ninomiya, Fumihito Hirai, Takashi Nagahama, Takashi Hisabe, Yasuhiro Takaki, Kenshi Yao, Hirotsugu Imaeda, Akira Andoh |
Intest Res. 2018;16(2):223-232. Published online April 30, 2018 DOI: https://doi.org/10.5217/ir.2018.16.2.223 |
Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study Mo1263 CRP, but Not CDAI is Associated With Enterocolonic Mucosal Healing in Crohn's Disease Treated With Infliximab; A Single Center Cohort Study W1279 Mucosal Healing With Methotrexate in Crohn's Disease: A Prospective Comparative Study With Azathioprine and Infliximab 405 High Infliximab Trough Levels are Associated With Mucosal Healing in Crohn's Disease Mucosal healing with methotrexate in Crohn’s disease: a prospective comparative study with azathioprine and infliximab Subtherapeutic Infliximab Trough Levels and Complete Mucosal Healing Are Associated With Sustained Clinical Remission After Infliximab Cessation in Paediatric-onset Crohn’s Disease Patients Treated With Combined Immunosuppressive Therapy Infliximab Trough Levels Are Associated With Mucosal Healing During Maintenance Treatment With Infliximab in Paediatric Crohn’s Disease P818 Polymorphisms in C1orf106, IL1RN, IL10 are associated with postinduction infliximab trough level in Crohn's disease patients Mo1413 Improved Mucosal Healing During Infliximab Maintenance Therapy Initiated Following Resection of Active Lesions in Crohn's Disease Patients Tu1150 Association of Serum Infliximab and Antibodies to Infliximab to Long-Term Clinical Outcome and Mucosal Healing in Crohn's Disease |